Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ISIS PHARMACEUTICALS INC Financial Overview

  • Income Statement: ISIS

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 107.19 M 69.62 M 37.57 M 35.05%
    Gross Profit 100.37 M 63.00 M 37.38 M 37.24%
    Net Income Before Extra Items/Preferred Div -11.96 M -136.30 M 124.34 M -1,039.39%
    Operating Income -13.06 M -38.95 M 25.89 M -198.22%
  • Cash Flow: ISIS

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 107.58 M 43.65 M 63.94 M 59.43%
    Net Cash Flow - Investing 234.24 M 55.64 M 178.60 M 76.25%
    Net Cash Flow/Operating Activities 212.03 M 36.09 M 175.94 M 82.98%
  • Balance Sheet: ISIS

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 574.15 M 258.86 M 315.29 M 54.91%
    Total Liabilities 469.90 M 248.62 M 221.29 M 47.09%
    Shareholders Equity 67.09 M 872,000.00 66.22 M 98.70%
  • Key Ratios / Statistics: ISIS

    • Valuation

      Price/Earnings (TTM) -109.08
      Price/Sales (TTM) 12.51
      Price/Book (MRQ) 5.53
      Price/Cash Flow (TTM) -4.32
    • Profitability

      Gross Margin 93.64
      Operating Margin -12.18
      Profit Margin -11.16
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 3.97
      Current Ratio (MRQ) 5.06
      Long Term Debt-to-Equity (MRQ) 45.11
    • Management Effectiveness

      Return on Equity (TTM) -37.12
      Return on Assets (TTM) -0.37
      Return on Investments (TTM) -3.62